Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07725419
NA

Transcutaneous Pulsed Radiofrequency for the Treatment of Diabetic Peripheral Neuropathy Pain

Sponsor: Algiamed Technologies USA, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine if a non-invasive, electrical pulsed radio frequency (PRF) device can relieve pain and improve function in patients suffering from diabetic nerve pain in their feet, known as pedal diabetic peripheral neuropathy. Patients with this condition often experience severe pain, burning sensations, numbness, and tingling. Current medications for diabetic nerve pain often have unwanted side effects or do not provide sufficient relief. In this single-blind, randomized trial, participants are assigned to receive either an active PRF treatment or a placebo (sham) treatment. Both treatments involve placing the device safely behind the knee (targeting the sciatic nerve) for 10 minutes, once a week for 3 weeks. The main question this study aims to answer is whether the active PRF treatment reduces nerve pain and symptoms significantly more than the placebo, measured by standard symptom questionnaires over a 6-month period.

Official title: Can a Non-interventional Pulsed Radiofrequency Device Relieve Pain and Improve Function in Patients With Diabetic Neuropathy That Are Refractory to Medication? A Single Blind Randomized Placebo-controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

92

Start Date

2016-12

Completion Date

2019-08

Last Updated

2026-07-24

Healthy Volunteers

No

Interventions

DEVICE

NMS 460 Pulsed Radio Frequency Device

Active transcutaneous electrical pulsed radio frequency stimulation. The device is applied bilaterally at the sciatic nerve in the popliteal fossa for 10 minutes, once weekly for 3 consecutive weeks.

DEVICE

Placebo Device

A sham device designed to look and operate like the active device but delivering no therapeutic current. It is applied bilaterally at the sciatic nerve in the popliteal fossa for 10 minutes, once weekly for 3 consecutive weeks to mimic the active treatment.

Locations (5)

Centre for Diabetes and Endocrinology (CDE), Houghton

Johannesburg, Gauteng, South Africa

Clinical Sites - West Johannesburg

Johannesburg, Gauteng, South Africa

Diabetic Clinic at the Charlotte Maxeke Hospital

Johannesburg, Gauteng, South Africa

Clinical Sites - Krugersdorp

Krugersdorp, Gauteng, South Africa

CDE / Clinical Sites - Pretoria

Pretoria, Gauteng, South Africa